Physician

Rafael O Robledo, M.D.

According to 2025 Medicare claims, Rafael Robledo, M.D. (NPI: 1497965198) practices internal medicine in the Hammond, LA market, with the plurality of this provider's patient population coming from Tangipahoa, LA. This provider's primary affiliated billing organization is INTERNAL MEDICINE CLINIC OF TANGIPAHOA, LLC (NPI: 1588678494; TIN: 030417452) and primary practice location at 70403-2412. Robledo is affiliated with the Imperium Clinical Partners II, LLC (ACO ID: A5523), participating under the MSSP model.

Robledo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 558 traditional Medicare patients, billed 4,323 HCPCS/CPT codes, and received $301,760 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 27,263 prescription claims across 730 beneficiaries totaling $2,100,145 in drug costs, led by Eliquis (Apixaban). DME data shows 217 claims. Open Payments data shows 33 records totaling $1,461. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $730,262 to $2,100,145. For DME billing, reported payments moved sharply higher in recent years, from $52,687 to $140,068.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	803	5,643	$369,660
2016	763	4,928	$326,677
2017	738	5,098	$344,559
2018	640	3,721	$231,536
2019	606	5,330	$324,917
2020	517	4,883	$298,460
2021	598	5,513	$339,078
2022	574	5,724	$340,496
2023	672	6,705	$382,457
2024	558	4,323	$301,760

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	603	8,920	$730,262
2016	539	9,592	$740,949
2017	551	9,394	$627,601
2018	526	7,646	$565,003
2019	527	13,920	$805,368
2020	509	15,287	$1,004,133
2021	527	14,502	$994,159
2022	584	17,473	$1,163,627
2023	708	20,389	$1,534,120
2024	730	27,263	$2,100,145

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	144	714	$31,384
2016	179	773	$36,360
2017	47	731	$30,411
2018	53	527	$15,118
2019	44	455	$12,779
2020	39	352	$37,081
2021	24	239	$31,217
2022	N/R	126	$7,932
2023	N/R	150	$6,481
2024	13	217	$56,374

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	144	201	$128
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	182	647	$92
99239	Hospital discharge day management, more than 30 minutes	165	254	$88
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	187	822	$62
99308	Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, 20 minutes or more	143	414	$56

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	703	13,482	$275,242
Ozempic	Semaglutide	134	4,038	$133,296
Farxiga	Dapagliflozin Propanediol	205	4,938	$96,808
Entresto	Sacubitril/Valsartan	173	3,677	$85,365
Mounjaro	Tirzepatide	56	2,008	$74,475

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A6021	Collagen dressing, sterile, size 16 sq. in. or less, each	N	N/R	17	$17,154
A6197	Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing	N	N/R	11	$13,406
A6010	Collagen based wound filler, dry form, sterile, per gram of collagen	N	N/R	12	$9,741
A6199	Alginate or other fiber gelling dressing, wound filler, sterile, per 6 inches	N	N/R	13	$5,893
A6196	Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing	N	13	26	$5,777

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	33	$1,461	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rafael O. Robledo, M.D.?

Tedicare shows public-source Medicare data for Rafael O. Robledo, M.D. (NPI 1497965198), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rafael O. Robledo, M.D. have ACO affiliation data?

Rafael O. Robledo, M.D. is shown with ACO affiliation data for Imperium Clinical Partners II, LLC (MSSP, ACO ID A5523).

What billing organization is linked to Rafael O. Robledo, M.D.?

Rafael O. Robledo, M.D. is linked to INTERNAL MEDICINE CLINIC OF TANGIPAHOA, LLC (billing NPI 1588678494) in the available physician profile data.

Does Rafael O. Robledo, M.D. have Open Payments data?

Rafael O. Robledo, M.D. has 33 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.